Comparison of mortality in patients on chemotherapy or immunotherapy during and before COVID-19 pandemic. Multicenter matched cohort study in Argentina
CONCLUSIONS.: Our findings show that the mortality rate of unvaccinated ambulatory patients on active intravenous oncology treatment during the COVID-19 pandemic did not increase.PMID:38232262 | DOI:10.17843/rpmesp.2023.402.12519
Source: Revista Peruana de Medicina de Experimental y Salud Publica - Category: International Medicine & Public Health Authors: Boris Itkin Samanta Straminsky Hern án Cáceres Mariana Onassis Agust ín Emilio García Laura Avanzi Lucia Kaminszczik Richard Serna Sejas Mara Rapaccioli Gustavo Billordo Dami án Lavaccara Juli án Lanzavecchia Luz Gibbons Eugenia Settecase Ariel Bard Source Type: research
More News: Argentina Health | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | COVID-19 | Health Insurance | Immunotherapy | Insurance | International Medicine & Public Health | Outbreaks | Pandemics | Peru Health | Study